Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
11/2009
11/11/2009EP1915379B1 Olanzapine analogs and methods of use thereof
11/11/2009CN101578287A Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
11/11/2009CN101575344A Method for preparing high-purity pseudo-polymorphic lavo-ofloxacin hemihydrate
11/11/2009CN100558730C Garcinia acid derivatives, preparation method and application thereof in pharmacy
11/11/2009CN100558728C Calcitonin gene related peptide receptor antagonists
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/10/2009US7615573 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease
11/10/2009CA2476257C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
11/10/2009CA2382117C 4-substituted piperidine compound
11/05/2009WO2009134952A2 Potent conjugates and hydrophilic linkers
11/05/2009WO2009133135A1 Spiro (piperidine-4, 2 ' -pyrrolidine) -1- (3, 5- trifluoromethyl phenyl) methylcarboxamides as nk1 tachikynin receptor antagonists
11/05/2009WO2009132986A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors
11/05/2009WO2009132921A1 Spiro-indole derivatives for the treatment of parasitic diseases
11/05/2009WO2009104147A3 Azatricyclic antibiotic compounds
11/05/2009WO2009006243A8 Processes for preparing bicyclic oxazine carboxaldehyde and beta-lactamase inhibitors
11/05/2009US20090275573 Imidazolidinone Derivatives as 11B-HSD1 Inhibitors
11/05/2009US20090275572 Fab i inhibitors
11/05/2009US20090275558 Substituted sulfonamide compounds
11/05/2009US20090275523 Spirocyclic nitriles as protease inhibitors
11/05/2009US20090275062 Extracting tacrolimus in a non-precipitating, non-denaturing aqueous environment, eliminates use of organic solvents and centrifugation, also fulfills the requirements for full automation of tacrolimus quantification assays
11/05/2009US20090274947 Imidazolidinone nitroxides as electrode materials for energy storage devices
11/05/2009US20090274656 Hepatitis c virus inhibitors
11/05/2009CA2723062A1 Spiro (piperidine-4, 2 ' -pyrrolidine) -1- (3, 5- trifluoromethylphenyl) methylcarboxamides as nk1 tachikynin receptor antagonists
11/05/2009CA2722487A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors
11/05/2009CA2720516A1 Indoline anti-cancer agents
11/05/2009CA2719365A1 Spiro-indole derivatives for the treatment of parasitic diseases
11/04/2009EP2113230A2 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
11/04/2009EP1617806B1 Selective spirocyclic glucocorticoid receptor modulators
11/04/2009EP1481077B1 Mitotic kinesin inhibitors
11/04/2009EP0879236B1 Derivatives of camptothecin for use in treating cancer
11/04/2009CN101573360A Heteroaryl compounds, compositions thereof, and methods of treatment therewith
11/03/2009US7612199 Polymorphic forms α, β, and γ of rifaximin
11/03/2009US7612089 N-[4-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenyl]-2N-(4-chlorophenylaminocarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide; thrombosis; inhibits coagulation of a blood sample
11/03/2009US7612087 Heterocyclic compounds as inhibitors of beta-lactamases
11/03/2009US7612086 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation
11/03/2009US7612078 Piperidinylamino-thieno[2,3-D] pyrimidine compounds
11/03/2009US7612063 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer
11/03/2009US7612055 Macrocyclic lactams and pharmaceutical use thereof
11/03/2009CA2383327C Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
11/03/2009CA2360767C Tricyclic benzodiazepines as vasopressin receptor antagonists
11/03/2009CA2316356C Benzoxazine compounds for enhancing synaptic response
10/2009
10/29/2009WO2009131926A1 Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
10/29/2009WO2009131237A1 Harmful arthropod control composition, and fused heterocyclic compound
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130560A1 Fused pyrimidineone compounds as trpv3 modulators
10/29/2009US20090270621 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
10/29/2009US20090270467 5-[(1S,3S,4R)-3-Amino-4-(2,4,5-trifluorophenyl)cyclohexyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-amine, used for treating insulin resistance, hyperglycemia and non-insulin dependent diabetes in mammals
10/29/2009US20090270446 Diamine derivatives
10/29/2009US20090270441 Macrolides
10/29/2009US20090270405 nicotinic receptor ligands such as N-(benzo[d]thiazol-2-yl)-4H-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octan]-2-amine, used for the treatment of nervous system, psychological and neurodegenerative disorders; treatment of schizophrenia or Alzheimer's Disease
10/29/2009US20090270383 Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
10/29/2009US20090270382 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270379 Quinolone derivatives useful as antibacterial agents
10/29/2009CA2722325A1 Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
10/29/2009CA2722159A1 Substituted phenylimidazole compounds and their use as ido inhibitors
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2721270A1 Harmful arthropod control composition, and fused heterocyclic compound
10/29/2009CA2720357A1 Fused pyrimidineone compounds as trpv3 modulators
10/28/2009EP2111396A1 Hcv inhibiting macrocyclic phenylcarbamates
10/28/2009EP1745052B9 Hiv integrase inhibitors: cyclic pyrimidinone compounds
10/28/2009EP1696914B1 3-cyano-quinoline derivatives with antiproliferative activity
10/28/2009CN101568543A Macrocyclic peptides as hepatitis c virus inhibitors
10/28/2009CN101568336A Macrocyclic peptides as hepatitis C virus inhibitors
10/28/2009CN101564571A Medical apparatus containing rapamycin analogue
10/27/2009US7608613 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
10/27/2009US7608564 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof
10/27/2009US7608420 Adding tetrahydrofuran to the fermentation broth, ultrafiltering the dilute broth, concentrating the permeate, adjusting the pH of the concentrate to at least pH 8.5 and collecting the precipitated staurosporine
10/27/2009CA2465534C Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
10/27/2009CA2415050C Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo[2,1-b][1,3]benzothiazepines
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/27/2009CA2318976C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
10/22/2009WO2009077956A3 HETEROCYCLIC INHIBITORS OF AN Hh-SIGNAL CASCADE, MEDICINAL COMPOSITIONS BASED THEREON AND METHODS FOR TREATING DISEASES CAUSED BY THE ABERRANT ACTIVITY OF AN Hh-SIGNAL SYSTEM
10/22/2009WO2008071961A8 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
10/22/2009US20090264405 Cetp Inhibitors
10/21/2009EP1781673B1 Selected fused heterocyclics and uses thereof
10/21/2009EP1346993B1 Lactam compounds and medical use thereof
10/21/2009CN101563347A Vasopressin V1a antagonists
10/21/2009CN101563345A Pharmaceutical compounds
10/20/2009US7605258 Preparing an individual isomer of mono-pegylated rapamycin 42 ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) by reacting an isomer of rapamycin with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid; use in treating nerve system cancer, leukemia, breast cancer, prostate cancer
10/20/2009US7605257 Acylation in presence of lipase
10/20/2009US7605169 Antibacterial agents
10/20/2009US7605157 Tricyclic tetrahydroquinoline antibacterial agents
10/20/2009CA2450122C Novel heterocyclic antibacterial compounds
10/20/2009CA2380852C Tricyclic compounds having spiro union
10/20/2009CA2378183C Antibacterial heterobicyclic substituted phenyl oxazolidinones
10/15/2009WO2009125809A1 Piperidine derivatives
10/15/2009WO2009125808A1 Aminocyclohexyl derivative
10/15/2009WO2009124746A1 Substituted sulfonamide derivatives
10/15/2009WO2009065920A3 Compounds
10/15/2009US20090258891 Macrocyclic Compounds As Antiviral Agents
10/15/2009US20090258864 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
10/15/2009CA2720879A1 Substituted sulfonamide derivatives
10/14/2009CN101558074A Epothilone analogues modified at positions C12-C13 as anticancer drugs
10/14/2009CN101555212A Synthesized micromolecule compound capable of conveying bioactivator and application thereof
10/14/2009CN100549008C Substituted oxazolidinones and their use in the field of blood coagulation
10/14/2009CN100549007C Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
10/14/2009CN100548296C Mitotic kinesin inhibitors
10/14/2009CN100548236C Medical devices containing rapamycin analogs
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601745 Nuclear factor kappa beta (NF-kB) inhibitors such as [4-(1H-Indol-3-yl)-piperidin-1-yl]-{2-[1-(pyrazine-2-carbonyl)-piperidin-4-yl]-thiazol-4-yl}-methanone
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 220